[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368711-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368711-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","molecular-and-morphological-alterations-in-breast-tissue-of-transgender-patients-undergoing-dihydrotestosterone-therapy","Molecular and morphological alterations in breast tissue of transgender patients undergoing dihydrotestosterone therapy","","Many patients undergoing gender-affirming surgery (GAS) choose reconstructive procedures to shape a more masculine chest contour rather than total mastectomy. The effects of dihydrotestosterone (DHT) on breast tissue morphology and molecular signaling are not well defined. This study quantifies morphological changes and protein expression across nontreatment, short-term (\u003C12 months), and long-term (≥12 months) DHT groups using receptor staining and spatial profiling. Atrophy and secretory changes vary significantly among groups; ER and AR correlations are strong, and multiple biomarker shifts associate with benign and cancerous tissue, supporting further investigation into breast cancer development.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/molecular-and-morphological-alterations-in-breast-tissue-of-transgender-patients-undergoing-dihydrotestosterone-therapy/368711/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/molecular-and-morphological-alterations-in-breast-tissue-of-transgender-patients-undergoing-dihydrotestosterone-therapy/368711.png","ImageObject",300,407,{"name":42,"@type":43},"Stanley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about DHT and breast tissue?","Question",{"text":63,"@type":64},"It evaluates whether dihydrotestosterone (DHT) treatment causes measurable morphological and molecular changes in breast tissue of transgender patients before gender-affirming surgery.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were participants grouped for DHT exposure in the analysis?",{"text":68,"@type":64},"Breast tissue samples were categorized into nontreatment, short-term treatment (STT, \u003C12 months), and long-term treatment (LTT, ≥12 months) groups.",{"name":70,"@type":61,"acceptedAnswer":71},"Which biomarkers and measurements showed group-dependent differences?",{"text":72,"@type":64},"Morphological parameters differed by group, ER and AR levels were strongly correlated in STT and LTT, spatial profiling showed increased ER and higher AR in specific regions, and additional biomarker changes were observed in the LTT group.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368711,1790434700,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","OPEN ACCESS  \nCitation: Lee J, Foroughi M, Kung V, Ali R, Parikh S, McMonigal A, et al. (2025) Molecular and morphological alterations in breast tissue of transgender patients undergoing dihydrotestosterone therapy. PLoS One 20(7):  \ne0325034. [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0325034  \nEditor: Hideo Kato, Mie University Hospital: Mie Daigaku Igakubu Fuzoku Byoin, JAPAN Received: February 26, 2025  \nAccepted: May 6, 2025  \nPublished: July 29, 2025  \nCopyright: © 2025 Lee et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData availability statement: All relevant data are within the paper and its Supporting  Information files.  \nFunding: The author(s) received no specific funding for this work.  \nRESEARCH ARTICLE  \nMolecular and morphological alterations in breast tissue of transgender patients undergoing dihydrotestosterone therapy  \nJinho Lee1, Maryam Foroughi2, Vanderlene Kung2, Rabeka Ali2, Saachi Parikh2, Ann McMonigal3, Yun Yu3, Austin Nguyen4, Gabriel Zangirolani1, Lina Gao3, Joanna Pucilowska4, Ozlen Saglam2, *  \n1 Department of Biology, Knight Cancer Center, Portland, Oregon, United States of America,  \n2 Department of Pathology and Laboratory Medicine, Oregon Health and Science University, Portland, Oregon, United States of America, 3 Department of Biostatistics, Knight Cancer Center, Portland-Oregon, United States of America, 4 Department of Immune Monitoring and Therapeutic Analytics, Knight Cancer Center, Portland, Oregon, United States of America  \n* [saglam@ohsu.edu](saglam@ohsu.edu)  \nAbstract  \nMany patients undergoing gender-affirming surgery (GAS) opt for reconstructive procedures rather than total mastectomy to achieve a more masculine chest contour. The impact of dihydrotestosterone (DHT) treatment on breast tissue remains unclear. This study evaluates the morphological changes and protein expression levels in breast tissue associated with hormonal and molecular pathways in patients receiving short-term or long-term DHT treatment before GAS. A total of 230 breast tissue samples were categorized into three groups: nontreatment, short-term treatment (STT, \u003C 12 months), and long-term treatment (LTT, ≥ 12 months) . Paired samples (n = 33) were stained for estrogen receptor (ER) and androgen receptor (AR) . NanoString Digital Spatial Profiling (DSP) analysis was conducted on a subset (n = 17), including two incidental breast cancer (BC) cases. Among morphological parameters assessed, atrophy and secretory changes differed significantly among groups. In the LTT group, ER-alpha expression was elevated in lactiferous ducts, while AR H-scores were higher in both STT and LTT groups. ER andAR expression levels were strongly correlated in the STT and LTT groups (r = 0.93–0.99) . DSP analysis revealed increased ER expression in the treated groups and higher AR expression in peripheral lobules of the LTT group (log2FC = 1.3, p = 0.03) . Ki-67, CDK6, and CD45 levels decreased in the LTT group, while INPP4B and BCL6 increased. DHT treatment leads to significant morphological and molecular changes in both benign and cancerous breast tissue. Altered expression of biomarkers such as INPP4B and CD45 in the LTT group and breast cancer samples suggests a potential role in BC development, warranting further investigation.  \nPLOS One | [https://doi.org/10.1371/journal.pone.0325034](https://doi.org/10.1371/journal.pone.0325034) July 29, 2025 1 / 14  \nCompeting interests: The authors have declared that no competing interest exist.  \nIntroduction  \nGender dysphoria refers to the psychological distress or discomfort arising from a mismatch between an individual’s gender identity and the sex assigned at birth. Population-based surveys estimate that 580 out of every 100,000 people in the United States identi","cbCaibJFF4lFw7xa","https://ap.wps.com/l/cbCaibJFF4lFw7xa","pdf",1470104,14,"English","# Abstract\n# Introduction\n## Gender dysphoria and transgender population estimates\n## Trends in gender-affirming surgeries and chest reconstruction\n## Role of dihydrotestosterone and knowledge gap\n## Study aims and experimental overview","[{\"question\":\"What question does the study address about DHT and breast tissue?\",\"answer\":\"It evaluates whether dihydrotestosterone (DHT) treatment causes measurable morphological and molecular changes in breast tissue of transgender patients before gender-affirming surgery.\"},{\"question\":\"How were participants grouped for DHT exposure in the analysis?\",\"answer\":\"Breast tissue samples were categorized into nontreatment, short-term treatment (STT, \\u003c12 months), and long-term treatment (LTT, ≥12 months) groups.\"},{\"question\":\"Which biomarkers and measurements showed group-dependent differences?\",\"answer\":\"Morphological parameters differed by group, ER and AR levels were strongly correlated in STT and LTT, spatial profiling showed increased ER and higher AR in specific regions, and additional biomarker changes were observed in the LTT group.\"}]","Molecular and morphological alterations in breast tissue of transgender patients undergoing dihydrotestosterone therapy | PDF",1790178144,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/efbe794a3b959b5be96610f471309aee.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/494cc7fbc18a530dbef6c3ad7f5e1c82.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/17ed321d5cded761446fab79f43aefee.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c9c5eeb35f6df7fd23b4628af6c75a9f.webp",980,1268]